Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Tongji Hospital | OTHER |
| Beijing Hospital | OTHER_GOV |
| Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | OTHER |
Not provided
Not provided
Not provided
Not provided
With the emergence of advanced technology to date in the artificial intelligence (AI), computer aided diagnosis has gradually gained its popularity in the field of healthcare. Particularly, in the clinical practice of coronary artery disease diagnosis, the application of AI could be of great implication in alleviating the shortage of medical sources. To evaluate the effectiveness and safety of the AI-based coronary CT angiographic analysis software (RuiXin-CoronaryAI) for diagnosis of coronary artery stenosis, a retrospective, multi-center, cross-over designed, blinded, sensitivity superiority and specificity non-inferiority clinical trial will be conducted.
Patients ≥18 years old with suspected or known coronary artery disease who underwent CCTA will be included. CCTA images of subjects should be of good quality up to the DICOM 3.0 standards, obtained by CT scan with ≥64-slices. The subjects with unqualified CTA will be excluded. CCTA images will be analyzed in three methods (3 groups). Control group: CCTA images will be visually evaluated by physicians. Experiment group: CCTA images will be evaluated by physicians using RuiXin-CoronaryAI. Reference group: CCTA images will be visually evaluated by cardiologists with at least 10 years experiences, and the conclusions they offer will be used as golden standard. Primary outcomes are diagnostic sensitivity and specificity of RuiXin-CoronaryAI and coronary CTA for diagnosis of ischemia on a per-vessel basis. The effectiveness of RuiXin-CoronaryAI for diagnosis of coronary artery stenosis will be conducted by testing superiority of diagnostic sensitivity and non-inferiority of specificity.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Control group | CCTA images will be visually evaluated by physicians. | ||
| Experiment group | CCTA images will be evaluated by physicians using RuiXin-CoronaryAI. |
| |
| Reference group | CCTA images will be visually evaluated by cardiologists with at least 10 years experiences, and the conclusions they offer will be used as golden standard. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| RuiXin-CoronaryAI software | Device | RuiXin-CoronaryAI, based on Computed Tomography Angiography (CTA) and was independently designed by RaysightMed Inc., which has been already authorized by National Medical Products Administration (NMPA). |
| Measure | Description | Time Frame |
|---|---|---|
| Per-vessel diagnostic sensitivity of RuiXin-CoronaryAI for diagnosis of coronary artery stenosis | Outcome measures were comparing RuiXin-CoronaryAI to CTA on a per-vessel basis | 1 day; Incident time for CTA examination was dependent on the length of time on the CT scaner. RuiXin-CoronaryAI examination was done remotely at Raysight's processing center in Shenzhen with a turnaround time of 24 hours from CT scan. |
| Per-vessel diagnostic specificity of RuiXin-CoronaryAI for diagnosis of coronary artery stenosis | Outcome measures were comparing RuiXin-CoronaryAI to CTA on a per-vessel basis | 1 day; Incident time for CTA examination was dependent on the length of time on the CT scaner. RuiXin-CoronaryAI examination was done remotely at Raysight's processing center in Shenzhen with a turnaround time of 24 hours from CT scan. |
| Measure | Description | Time Frame |
|---|---|---|
| Per-patient diagnostic sensitivity of RuiXin-CoronaryAI for diagnosis of coronary artery stenosis | Outcome measures were comparing RuiXin-CoronaryAI to CTA on a per-patient basis | 1 day; Incident time for CTA examination was dependent on the length of time on the CT scaner. RuiXin-CoronaryAI examination was done remotely at Raysight's processing center in Shenzhen with a turnaround time of 24 hours from CT scan. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Patients ≥18 years old with suspected or known coronary artery disease who underwent CCTA examination.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Liming Xia | Contact | 13607176908 | lmxia@tjh.tjmu.edu.cn | |
| Lihui Li | Contact | 13636480344 | lihui.li@raysightmed.com |
| Name | Affiliation | Role |
|---|---|---|
| Liming Xia | Tongji Hospital | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Beijing Hospital | Recruiting | Beijing | Beijing Municipality | 100730 | China |
Not provided
Not provided
Not provided
Not provided
| Per-patient diagnostic specificity of RuiXin-CoronaryAI for diagnosis of coronary artery stenosis | Outcome measures were comparing RuiXin-CoronaryAI to CTA on a per-patient basis | 1 day; Incident time for CTA examination was dependent on the length of time on the CT scaner. RuiXin-CoronaryAI examination was done remotely at Raysight's processing center in Shenzhen with a turnaround time of 24 hours from CT scan. |
| Sun Yat-sen Memorial Hospital | Recruiting | Guangzhou | Guangdong | 510120 | China |
|
| Tongji Hospital | Recruiting | Wuhan | Hubei | 430030 | China |
|
| ID | Term |
|---|---|
| D003324 | Coronary Artery Disease |
| D023921 | Coronary Stenosis |
| ID | Term |
|---|---|
| D003327 | Coronary Disease |
| D017202 | Myocardial Ischemia |
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |
| D001161 | Arteriosclerosis |
| D001157 | Arterial Occlusive Diseases |
| D014652 | Vascular Diseases |
Not provided
Not provided